A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhong, Ting ^a   Yao, Xin ^a   Zhang, Shuang ^a   Guo, Yang ^a   Duan, Xiao Chuan ^a   Ren, Wei ^a   Dan, H ^a   Yin, Yi Fan ^a   Zhang, Xuan ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CONJUGATED LINOLEIC ACID; DRUG CARRIER; PACLITAXEL;

ANIMAL; CHEMISTRY; DRUG SCREENING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MOUSE; NANOMEDICINE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; X RAY DIFFRACTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; LINOLEIC ACIDS, CONJUGATED; MALE; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON, TRANSMISSION; NANOMEDICINE; PACLITAXEL; X-RAY DIFFRACTION;

EID: 84994589774     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36614     Document Type: Article

References (31)

1. Wicki, A., Witzigmann, D., Balasubramanian, V., Huwyler, J. Nanomedicine in cancer therapy: challenges, opportunities, clinical applications. J. Control Release 200, 138-157 (2015).
2. Sun, T. et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. Engl. 53, 12320-12364 (2014).
3. Dawidczyk, C. M. et al. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. J. Control Release 187, 133-144 (2014).
4. Maksimenko, A. et al. A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity. Proc. Natl. Acad. Sci. USA 111, E217-E226 (2014).
5. Kopeek, J. Polymer-drug conjugates: origins, progress to date and future directions. Adv. Drug Deliv. Rev. 65, 49-59 (2013).
6. Pang, X., Du, H. L., Zhang, H. Q., Zhai, Y. J., Zhai, G. X. Polymer-drug conjugates: present state of play and future perspectives. Drug Discov. Today 18, 1316-1322 (2013).
7. Luo, C., Sun, J., Sun, B., He, Z. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy. Trends Pharmacol. Sci. 35, 556-566 (2014).
8. Lepeltier, E., Bourgaux, C., Couvreur, P. Nanoprecipitation and the "Ouzo effect": Application to drug delivery devices. Adv. Drug Deliv. Rev. 71, 86-97 (2014).
9. Li, C., Wallace, S. Polymer-drug conjugates: recent development in clinical oncology. Adv. Drug Deliv. Rev. 60, 886-898 (2008).
10. Zhang, H., Zhai, Y., Wang, J., Zhai, G. New progress and prospects: The application of nanogel in drug delivery. Mater. Sci. Eng. C. Mater. Biol. Appl. 60, 560-568 (2016).
11. Clementi, C., Miller, K., Mero, A., Satchi-Fainaro, R., Pasut, G. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms. Mol. Pharm. 8, 1063-1072 (2011).
12. Zhang, R. et al. Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel. J. Control Release 166, 66-74 (2013).
13. Wei, X., Senanayake, T. H., Warren, G., Vinogradov, S. V. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. Bioconjug. Chem. 24, 658-668 (2013).
14. Shen, Y. et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J. Am. Chem. Soc. 132, 4259-4265 (2010).
15. Huang, P. et al. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J. Am. Chem. Soc. 136, 11748-11756 (2014).
16. Dosio, F. et al. Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, biological evaluation. Bioconjug. Chem. 21, 1349-1361 (2010).
17. Wang, Y. et al. Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines. Nano Lett. 14, 5577-5583 (2014).
18. Ke, X. Y. et al. The therapeutic efficacy of conjugated linoleic acid-paclitaxel on glioma in the rat. Biomaterials 31, 5855-5864 (2010).
19. Li, D. et al. Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings. Int. J. Nanomedicine 7, 6105-6114 (2012).
20. Li, J. S. et al. In vitro and in vivo antitumor efficacy of CLA-PTX on B16-F10 melanoma cells. J. Chin. Pharm. Sci. 23, 46-53 (2014).
21. Du, R. et al. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma. Int. J. Nanomedicine 9, 3091-3105 (2014).
22. Song, P. et al. The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug. Oncotarget. 7, 48467-48480 (2016).
23. Huang, D. et al. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy. Oncotarget. 7, 43616-43628 (2016).
24. Che, J., Okeke, C. I., Hu, Z. B., Xu, J. DSPE-PEG: a distinctive component in drug delivery system. Curr. Pharm. Des. 21, 1598-1605 (2015).
25. Zhao, B. J. et al. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats. J. Drug Target 19, 382-390 (2011).
26. Mao, X. et al. iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells. Nanomedicine (Lond) 10, 2677-2695 (2015).
27. Gill, K. K., Kaddoumi, A., Nazzal, S. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines. Eur. J. Pharm. Sci. 46, 64-71 (2012).
28. Della Rocca, J., Liu, D., Lin, W. Are high drug loading nanoparticles the next step forward for chemotherapy Nanomedicine (Lond). 7, 303-305 (2012).
29. Liu, Y., Kathan, K., Saad, W., Prud'homme, R. K. Ostwald ripening of beta-carotene nanoparticles. Phys. Rev. Lett. 98, 036102 (2007).
30. An, B. K. et al. Color-tuned highly fluorescent organic nanowires/nanofabrics: easy massive fabrication and molecular structural origin. J. Am. Chem. Soc. 131, 3950-3957 (2009).
31. Kasai, H. et al. Creation of pure nanodrugs and their anticancer properties. Angew. Chem. Int. Ed. Engl. 51, 10315-10318 (2012).